Home › Scleroderma › Iowa › Cedar Rapids
Scleroderma clinical trials in Cedar Rapids, IA
3 studies for Scleroderma are looking for participants at sites in and around Cedar Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- University of Iowa, Iowa City · 25 mi away
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RecruitingPhase 1
- University of Iowa, Iowa City · 25 mi away
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
- Artiva Investigational Site Iowa, Iowa City · 25 mi away
About Scleroderma
Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.
More about Scleroderma on MedlinePlus
Scleroderma trials in other cities
- New York City, NY10 studies
- Ann Arbor, MI9 studies
- Houston, TX8 studies
- Chicago, IL8 studies
- Los Angeles, CA7 studies
- Boston, MA7 studies
- Durham, NC7 studies
- Baltimore, MD6 studies
- Dallas, TX5 studies
- New Orleans, LA5 studies
- Miami, FL5 studies
- Philadelphia, PA5 studies
Other studies in Cedar Rapids
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer17 studies
- Cancer (all types)17 studies
- Lung Cancer17 studies
- Multiple Myeloma16 studies
- Acute Myeloid Leukemia15 studies
- Colorectal Cancer14 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Prostate Cancer12 studies
- Melanoma11 studies
- Metastatic Cancer9 studies
- Blood Cancers9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.